REPLY: Portal Pressure in Non-Cirrhotic Portal Hypertension: To Measure or Not to Measure.
We appreciate the interest in our work and the commentary provided by Professor Kumar and colleagues. To clarify, we do believe that hepatic venous pressure gradient (HVPG) measurement is a viable clinical tool that can be used in addition to liver biopsy in distinguishing non-cirrhotic portal hypertension (NCPH) versus cirrhosis. However, this is rarely necessary unless tissue sample obtained during the biopsy is insufficient. Performance of HVPG measurements, compared to percutaneous liver biopsy, subject patients to prolonged procedure times, requires additional allocation of medical resources, all while resulting in smaller and narrower cores that make histologic interpretation less reliable.(1) The latter being the most crucial liability as the tissue itself is the gold standard in differentiating NCPH from cirrhosis.